NCT06629675Recruiting
Make Every Step Count: Personalised Music Feedback to Walking for People Living With COPD
Personalised Music Feedback to Optimise Adherence to the Walking Exercise Prescription During Pulmonary Rehabilitation for Individuals Living With Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 16 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Pulmonary Rehabilitation (PR) is an evidence-based intervention to effectively manage the physiological and psychological effects of Chronic Obstructive Pulmonary Disease (COPD). The aims of PR are to improve symptoms of COPD, increase exercise capacity, increase independency, improve overall behaviour related to health (like exercising more), and enhance quality of life. The cornerstone of PR programmes is aerobic exercise prescription. Typically, walking exercise is used, and the prescription is individualised for each patient based on their maximal walking exercise capacity. However, adherence to walking exercise is challenging for service users, particularly when unsupervised at home. The use of music during exercise shows promise as a tool to decrease the perception of fatigue and increase motivation, but the integration of music via smartphone applications to support walking exercise adherence during PR has not been explored. This project aims to assess if a new mobile application BeatClearWalker (BCW) intervention is practical, acceptable, and effectively used by people living with COPD. The app is designed to help people living with COPD attending PR adhere to their prescribed walking pace during exercise. The BCW app provides real-time, personalised music feedback through music degradation to optimise the dose of walking exercise.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 26 Sept 2024
- Start date
- 20 Apr 2025
- Primary completion date
- 12 Sept 2025
- Lead sponsor
- University of Leicester
- Diseases
- COPD
- NCT number
- NCT06629675
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 20 Apr 2025 to the primary completion date, 12 Sept 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Has had a cardiac event within last 6 weeks
- Severe psychiatric disorders
- Patients with a history of MRSA +ve screens (patients can be assessed and given an exercise programme but cannot attend the classes. Patients need to have 3 consecutive -ve MRSA swabs before they can attend).
Other
- Unable to provide valid informed consent.
- Lack of motivation to participate in PR programme.
- Any-contra-indications absolute or relative to exercise training.
- Unable to understand written or spoken English.
Who the study is looking for
- Willing and able to provide informed consent for participation in the study.
- The patient is referred for PR at the UHL.
- The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria)
- Male or female, aged 18+ years.
- Able to communicate in written and spoken English.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NIHR Leicester Biomedical Research Centre - Respiratory Coordinator of this site? Confirm its status | Leicester | United Kingdom | Not yet recruiting |
| University Hospitals of Leicester (UHL) Coordinator of this site? Confirm its status | Leicester | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.